Ender Kurt

509 total citations
33 papers, 380 citations indexed

About

Ender Kurt is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ender Kurt has authored 33 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Ender Kurt's work include Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Lung Cancer Research Studies (4 papers). Ender Kurt is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Lung Cancer Research Studies (4 papers). Ender Kurt collaborates with scholars based in Türkiye. Ender Kurt's co-authors include Türkkan Evrensel, Osman Manavoğlu, Özkan Kanat, Mutlu Demiray, Güzin Gönüllü, Hülya Öztürk, Ahmet Tunalı, Vildan Özkocaman, Tülay Özçelik and Ülkü Özan and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and BMC Cancer.

In The Last Decade

Ender Kurt

32 papers receiving 363 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ender Kurt 217 100 72 66 58 33 380
Orhan Türken 157 0.7× 65 0.7× 48 0.7× 46 0.7× 70 1.2× 32 491
Karan Seegobin 81 0.4× 107 1.1× 42 0.6× 57 0.9× 31 0.5× 56 281
Kotaro Kitani 113 0.5× 128 1.3× 32 0.4× 53 0.8× 163 2.8× 45 366
Jean‐François Egger 114 0.5× 72 0.7× 43 0.6× 54 0.8× 173 3.0× 14 374
Harris Naina 122 0.6× 60 0.6× 18 0.3× 58 0.9× 116 2.0× 60 356
Brent T. Xia 177 0.8× 167 1.7× 39 0.5× 59 0.9× 152 2.6× 25 456
Masashi Miguchi 169 0.8× 100 1.0× 41 0.6× 200 3.0× 131 2.3× 53 469
Paul Zorsky 208 1.0× 56 0.6× 38 0.5× 82 1.2× 37 0.6× 16 399
Mohammed Ilyas 189 0.9× 125 1.3× 39 0.5× 71 1.1× 196 3.4× 22 461
Simon Meller 79 0.4× 60 0.6× 98 1.4× 97 1.5× 75 1.3× 14 489

Countries citing papers authored by Ender Kurt

Since Specialization
Citations

This map shows the geographic impact of Ender Kurt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ender Kurt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ender Kurt more than expected).

Fields of papers citing papers by Ender Kurt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ender Kurt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ender Kurt. The network helps show where Ender Kurt may publish in the future.

Co-authorship network of co-authors of Ender Kurt

This figure shows the co-authorship network connecting the top 25 collaborators of Ender Kurt. A scholar is included among the top collaborators of Ender Kurt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ender Kurt. Ender Kurt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Türe, Mehmet, et al.. (2016). Spectrum of EGFR gene mutations and ALK rearrangements in lung cancer patients in Turkey. SpringerPlus. 5(1). 482–482. 4 indexed citations
3.
Avcı, Nilüfer, Mehmet Türe, Erdem Çubukçu, et al.. (2015). Association and Prognostic Significance of the Functional −1562C/T Polymorphism in the Promoter Region of MMP-9 in Turkish Patients with Gastric Cancer. Pathology & Oncology Research. 21(4). 1243–1247. 8 indexed citations
4.
Avcı, Nilüfer, Gülşah Çeçener, Elif Ertürk, et al.. (2014). Molecular Markers for Patients with Thymic Malignancies: not Feasible at Present?. Asian Pacific Journal of Cancer Prevention. 15(8). 3457–3460. 2 indexed citations
5.
Çubukçu, Erdem, Özkan Kanat, Ömer Fatih Ölmez, et al.. (2013). Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer.. PubMed. 18(2). 359–65. 5 indexed citations
6.
Kurt, Ender, Erdem Çubukçu, Bülent Karabulut, et al.. (2013). A multi-institutional evaluation of carboplatin plus docetaxel regimen in elderly patients with advanced gastric cancer.. PubMed. 18(1). 147–53. 3 indexed citations
7.
Ölmez, Ömer Fatih, Türkkan Evrensel, Erdem Çubukçu, et al.. (2013). Prognostic Significance of Human Epidermal Receptor (HER)-3 Immunohistochemical Expression in Patients with Metastatic Breast Cancer. Asian Pacific Journal of Cancer Prevention. 14(7). 4115–4119. 2 indexed citations
8.
Bayrak, Muharrem, Ömer Fatih Ölmez, Ender Kurt, et al.. (2012). Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer. Clinical & Translational Oncology. 15(4). 307–312. 19 indexed citations
9.
Çubukçu, Erdem, et al.. (2011). Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: implications for patient outcome. Clinical & Translational Oncology. 13(11). 826–830. 4 indexed citations
10.
Sezgin, Canfeza, et al.. (2007). Efficacy of Lower Dose Capecitabine in Patients with Metastatic Breast Cancer and Factors Influencing Therapeutic Response and Outcome. Southern Medical Journal. 100(1). 27–32. 15 indexed citations
11.
Kanat, Özkan, Ender Kurt, Ulviye Yalçınkaya, Türkkan Evrensel, & Osman Manavoğlu. (2006). Comparison of uroprotective efficacy of mesna and amifostine in Cyclophosphamide- induced hemorrhagic cystitis in rats. Indian Journal of Cancer. 43(1). 12–12. 14 indexed citations
12.
Demiray, Mutlu, Ender Kurt, Türkkan Evrensel, et al.. (2005). Phase II Study of Gemcitabine Plus Paclitaxel in Metastatic Breast Cancer Patients with Prior Anthracycline Exposure. Cancer Investigation. 23(5). 386–391. 8 indexed citations
13.
Kanat, Özkan, Türkkan Evrensel, Ender Kurt, et al.. (2005). 5-Fluorouracil, epirubicin and cisplatin in the treatment of metastatic gastric carcinoma: A retrospective analysis of 68 patients. Indian Journal of Cancer. 42(2). 85–85. 13 indexed citations
14.
Özkalemkaş, Fahir, Vildan Özkocaman, Tülay Özçelik, et al.. (2005). The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: A clinical study of 19 cases. BMC Cancer. 5(1). 144–144. 96 indexed citations
15.
Kurt, Ender, Canfeza Sezgin, Türkkan Evrensel, et al.. (2005). Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma. International Journal of Clinical Practice. 59(5). 537–543. 6 indexed citations
16.
Gönüllü, Güzin, Canan Ersoy, Türkkan Evrensel, et al.. (2005). Relation between insulin resistance and serum concentrations of IL-6 and TNF-α in overweight or obese women with early stage breast cancer. Cytokine. 31(4). 264–269. 21 indexed citations
17.
Evrensel, Türkkan, Ender Kurt, Mutlu Demiray, et al.. (2005). Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients.. PubMed. 52(1). 43–5. 2 indexed citations
18.
Kanat, Özkan, Şaduman Balaban Adım, Türkkan Evrensel, et al.. (2004). Prognostic Value of <I>nm23</I> in Gastrointestinal Stromal Tumors. Medical Oncology. 21(1). 53–58. 6 indexed citations
19.
Ersoy, Alparslan, Metin Yavuz, İlker Ercan, et al.. (2003). Survival analysis of the factors affecting in mortality in injured patients requiring dialysis due to acute renal failure during the Marmara earthquake: Survivors vs non-survivors. Clinical Nephrology. 59(5). 334–340. 21 indexed citations
20.
Kanat, Özkan, Türkkan Evrensel, İbrahim Baran, et al.. (2003). Protective Effect of Amifostine Against Toxicity of Paclitaxel and Carboplatin in Non-small Cell Lung Cancer: A Single Center Randomized Study. Medical Oncology. 20(3). 237–246. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Orhan Türken Breakdown of academic impact, for papers by Karan Seegobin Breakdown of academic impact, for papers by Kotaro Kitani Breakdown of academic impact, for papers by Jean‐François Egger Breakdown of academic impact, for papers by Harris Naina Breakdown of academic impact, for papers by Brent T. Xia Breakdown of academic impact, for papers by Masashi Miguchi Breakdown of academic impact, for papers by Paul Zorsky Breakdown of academic impact, for papers by Mohammed Ilyas Breakdown of academic impact, for papers by Simon Meller
Rankless by CCL
2026